跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 718 条关于
“HJB”
全部
718
临床试验
346
药物
287
机构
5
资讯
80
3个月前
Inhibrx Reports Positive Phase 1/2 Data for Ozekibart in Colorectal Cancer, Plans FDA Filing for Chondrosarcoma
上个月
Transcenta Sells Hangzhou CDMO Plant to WuXi Biologics for RMB 190 Million, Then Licenses HiCB Platform Back to the Buyer
9天前
Transcenta Licenses HiCB Continuous Bioprocessing Platform to WuXi Biologics in Strategic CMC Collaboration
2个月前
Hemab Therapeutics Unveils HMB-002 Proof-of-Mechanism Data in VWD and Announces Novel Antifibrinolytic HMB-003 at ISTH 2026
去年
Triple-Combination Pill GMRx2 Shows Promise in Revolutionizing Hypertension Treatment
去年
China Leads Asia-Pacific's Rise as a Global Clinical Trial Hub
去年
FDA's Rare Disease Innovation Hub Aims to Accelerate Treatment Development
2年前
Brazil Emerges as Key Hub for Cancer Drug Clinical Trials
去年
FDA Accepts Resubmission of NDA for Rivoceranib and Camrelizumab in Unresectable Hepatocellular Carcinoma
11年前
Europe Emerges as Leading Hub for Precision Medicine Innovation and Implementation
第 1 页,共 8 页
上一页
下一页